Treatment of Early-Stage Colorectal Cancer
Key Points
Key Points
- Historically, some of the highest incidence rates for colorectal cancers have been in “more developed” regions. However, approximately 45% of these occur in “less developed” regions, representing 9-10% of cancers in those populations.
- Since different regions of the world, both among and within countries, differ with respect to resource access, ASCO has established a process for stratifying guidelines according to resource availability (basic, limited, enhanced and maximal – See Table 1). This framework emphasizes that variations occur not only between but also within countries—for example, between rural and urban areas.
Treatment
...eatmen...
...ework of Resource StratificationHaving trou...
...non-obstructing colon cancer Colon Cancer Sta...
...h non-obstructing, resectable, locali...
...ts with non-obstructing, resectable, localized...
...non-obstructing, resectable, localized colon canc...
...cer Stages IIB-IIC: T4N0 (Non-obstru...
...with non-obstructing, locally advanced (ie.,...
...on-obstructing, locally advanced (ie., with inva...
...with non-obstructing, locally advanced (ie.,...
...on-obstructing, locally advanced (ie....
...tients with non-obstructing, locally adv...
...with non-obstructing, locally advanced (...
Patients with non-obstructing, resect...
...ancer Stages IIB-IIC: T3N0 Obstructing or T4...
...ith obstructing, locally advanced (ie., with...
...with obstructing, locally advanced (ie....
...atients with obstructing, locally adv...
...structing, locally advanced (ie., with inva...
...with obstructing, locally advanced (ie.,...
...k Obstructing Colon Cancer and Colo...
...obstructing, locally advanced (ie.,...
...with high-risk, obstructing stage II colon ca...
...gh risk, obstructing stage III colon cancerMaxima...
...Stage I– clinical stage T1 N0...
...ients with nonmetastatic cT1N0 rec...
...h nonmetastatic cT1N0 rectal cancer...
...ts with select low risk (cT1N0 without adverse f...
...tal Cancer Stage I– clinical sta...
...nonmetastatic cT2N0 rectal cancerBasic an...
...h nonmetastatic cT2N0 rectal cancerEnhanced...
...nmetastatic cT2N0 rectal cancerMaximal...
...al Cancer Stage IIA– clinical stag...
...clinically resectable cT3N0 rectal cancerBasic a...
...clinically resectable cT3N0 rectal cance...
...s with clinically resectable cT3N0 recta...
...ents with clinically resectable cT3N0 rectal cance...
...inically resectable cT3N0 rectal cancer where ther...
...linically resectable cT3N0 rectal ca...
...ts with clinically resectable pT3N0 rectal c...
...atients with clinically resectable cT3N0 rectal...
...atients with clinically resectable cT3N0 rectal...
...lon Cancer Post-Treatment Surveillance...
...ients with Stage II CRCBasic Medical history,...
...nts with Stage II CRCLimited Me...
...eated patients with Stage II CRC a...
Treated patients with Stage II CRC at high r...
...ted patients with Stage II CRC at sta...
...rly-Stage Rectal Cancer Post-Treatm...
...with rectal cancerBasic Medical history, phy...
...reated patients with rectal cancer at st...
...patients with rectal cancer at high riskEnhanc...
...reated patients with rectal cancer who have n...
...ted patients with rectal cancer at st...
...ents with rectal cancer at standard risk who ha...
...ients with rectal cancer at high risk who h...
...s with rectal cancer, where a complete colonoscop...
...tients with rectal cancer at high risk who...
...y-Stage Colon Cancer Follow Up (summary)H...
...able 12. Early-Stage Rectal Cancer Follow Up...